Citigroup’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Citigroup’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-31,967	Closed	-$304K	–	5783
2023 Q1	$304K	Buy	+31,967	New	+$336K	﹤0.01%	3481
2022 Q3	–	Sell	-27	Closed	-$1K	–	6453
2022 Q2	$1K	Sell	27 -23	-46%	-$1.42K	﹤0.01%	6128
2022 Q1	$5K	Sell	50 -131	-72%	-$9.62K	﹤0.01%	5849
2021 Q4	$21K	Buy	181 +48	+36%	+$11.5K	﹤0.01%	5374
2021 Q3	$50K	Buy	133 +120	+923%	+$40.2K	﹤0.01%	4733
2021 Q2	$5K	Sell	13 -4	-24%	-$1.84K	﹤0.01%	5858
2021 Q1	$8K	Buy	+17	New	+$9.25K	﹤0.01%	5778

Other funds holding NEXI

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Allen Operations New York $722M AUM 20.02% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup's NEXI Position: Q2 2023 in Review

Citigroup sold out of NexImmune, Inc. Common Stock (NEXI) in Q2 2023, closing a stake of 31,967 shares — an estimated $304K sold.

Citigroup first reported a position in NEXI in Q1 2021 and held it in 7 quarters. The position peaked at $304K in Q1 2023. 32 funds tracked by Wall St. Rank hold NEXI as of Q2 2023.

Citigroup reported no remaining NexImmune, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Citigroup sold 31,967 NexImmune, Inc. Common Stock shares in Q2 2023, an estimated $304K.
Citigroup first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Citigroup's NexImmune, Inc. Common Stock position peaked at $304K in Q1 2023.
32 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q2 2023.

Based on Citigroup's 13F filing for Q2 2023, filed 10 Aug 2023.